{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:05:09Z","timestamp":1772816709226,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,25]],"date-time":"2017-11-25T00:00:00Z","timestamp":1511568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,11,25]],"date-time":"2017-11-25T00:00:00Z","timestamp":1511568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI100805"],"award-info":[{"award-number":["AI100805"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["200750"],"award-info":[{"award-number":["200750"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2292-x","type":"journal-article","created":{"date-parts":[[2017,11,25]],"date-time":"2017-11-25T01:47:41Z","timestamp":1511574461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"given":"Tara C.","family":"Bouton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick P. J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole D.","family":"Mitnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Peloquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Eisenach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramonde F.","family":"Patientia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Lecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Gotuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neel R.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas H.","family":"Diacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Martel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Santillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen Robergeau","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dante","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"von Groote-Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Seas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Dianis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Moreno-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"C. Robert","family":"Horsburgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,25]]},"reference":[{"key":"2292_CR1","unstructured":"WHO. Global Tuberculosis Report 2016. Geneva: World Health Organization; 2016."},{"key":"2292_CR2","unstructured":"WHO. WHO treatment guidelines for drug-resistant tuberculosis. 2016 Update (WHO\/HTM\/TB\/2016.04). Geneva: World Health Organization; 2016."},{"key":"2292_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","volume":"9","author":"EW Orenstein","year":"2009","unstructured":"Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9:153\u201361.","journal-title":"Lancet Infect Dis"},{"key":"2292_CR4","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1378\/chest.128.3.1406","volume":"128","author":"F Marra","year":"2005","unstructured":"Marra F, Marra CA, Moadebi S, Shi P, Elwood RK, Stark G, FitzGerald JM. Levofloxacin treatment of active tuberculosis and the risk of adverse events. Chest. 2005;128:1406\u201313.","journal-title":"Chest"},{"key":"2292_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S1473-3099(03)00671-6","volume":"3","author":"AS Ginsburg","year":"2003","unstructured":"Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis. 2003;3:432\u201342.","journal-title":"Lancet Infect Dis"},{"key":"2292_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/0091270004264643","volume":"44","author":"GJ Noel","year":"2004","unstructured":"Noel GJ, Goodman DB, Chien S, Solanki B, Padmanabhan M, Natarajan J. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings. J Clin Pharmacol. 2004;44:464\u201373.","journal-title":"J Clin Pharmacol"},{"key":"2292_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1056\/NEJMoa1313865","volume":"371","author":"AH Diacon","year":"2014","unstructured":"Diacon AH, Pym A, Grobusch MP, de Los Rios JM, Gotuzzo E, Vasilyeva I, Leimane V, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, De Paepe E, van Heeswijk RPG, Dannemann B. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med. 2014;371:723\u201332.","journal-title":"N Engl J Med"},{"key":"2292_CR8","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","volume":"366","author":"MT Gler","year":"2012","unstructured":"Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, Gao M, Awad M, Park S-K, Shim TS, Suh GY, Danilovits M, Ogata H, Kurve A, Chang J, Suzuki K, Tupasi T, Koh W-J, Seaworth B, Geiter LJ, Wells CD. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med. 2012;366:2151\u201360.","journal-title":"N Engl J Med"},{"key":"2292_CR9","unstructured":"WHO. Global tuberculosis report. 20th Edition. Geneva: World Health Organization; 2015."},{"key":"2292_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1067\/mcp.2000.111482","volume":"68","author":"JL D\u00e9molis","year":"2000","unstructured":"D\u00e9molis JL, Kubitza D, Tennez\u00e9 L, Funck-Brentano C. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects. Clin Pharmacol Ther. 2000;68:658\u201366.","journal-title":"Clin Pharmacol Ther"},{"key":"2292_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/cid\/cis664","volume":"55","author":"F Lapi","year":"2012","unstructured":"Lapi F, Wilchesky M, Kezouh A, Benisty JI, Ernst P, Suissa S. Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis. 2012;55:1457\u201365.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"2292_CR12","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1086\/651487","volume":"50","author":"WJ Burman","year":"2010","unstructured":"Burman WJ. Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century. Clin Infect Dis. 2010;50 Suppl 3:S165\u201372.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2292_CR13","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1086\/518137","volume":"45","author":"GL Drusano","year":"2007","unstructured":"Drusano GL. Pharmacokinetics and pharmacodynamics of antimicrobials. Clin Infect Dis. 2007;45 Suppl 1:S89\u201395.","journal-title":"Clin Infect Dis"},{"key":"2292_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1128\/AAC.01036-07","volume":"52","author":"CA Peloquin","year":"2008","unstructured":"Peloquin CA, Hadad DJ, Molino LPD, Palaci M, Boom WH, Dietze R, Johnson JL. Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis. Antimicrob Agents Chemother. 2008;52:852\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"2292_CR15","unstructured":"WHO. Global tuberculosis report 2013. Geneva: World Health Organization; 2013."},{"key":"2292_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-144-9-200605020-00008","volume":"144","author":"TH Holtz","year":"2006","unstructured":"Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med. 2006;144:650\u20139.","journal-title":"Ann Intern Med"},{"key":"2292_CR17","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S","volume":"17","author":"FY Hsieh","year":"1998","unstructured":"Hsieh FY, Bloch D a, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17:1623\u201334.","journal-title":"Stat Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2292-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-017-2292-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2292-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:14:58Z","timestamp":1589541298000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2292-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,25]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2292"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2292-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,25]]},"assertion":[{"value":"11 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Before the study began, the Institutional Review Boards of all involved institutions, including Boston University, Harvard University, University of Florida, University of Arkansas, Universidad Peruana Cayetano Heredia, Hospital San Juan de Lurigancho, Instituto Nacional de Salud, Stellenbosch University and South African Medicines Control Council, reviewed and approved the study protocol and informed consent documents. The study is being conducted under an investigational new drug (IND) from the US Food and Drug Administration (FDA). A list of the reference numbers for all ethical bodies that approved the study can be found in Additional\u00a0file\u00a0. Patients who meet the inclusion criteria (see Table\u00a0) are enrolled via the informed consent process. The approved consent form can be found in Additional\u00a0file .","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"563"}}